Seroatlas · Human Serome Atlas

MGMT

Methylated-DNA--protein-cysteine methyltransferase

Also known as: MGMT_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P16455
Gene
MGMT
Ensembl
ENSG00000170430
Chromosome
10
Canonical length
207 aa
Protein class
Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins
Subcellular location
Nucleoplasm

OverviewNCBI Gene

Alkylating agents are potent carcinogens that can result in cell death, mutation and cancer. The protein encoded by this gene is a DNA repair protein that is involved in cellular defense against mutagenesis and toxicity from alkylating agents. The protein catalyzes transfer of methyl groups from O(6)-alkylguanine and other methylated moieties of the DNA to its own molecule, which repairs the toxic lesions. Methylation of the genes promoter has been associated with several cancer types, including colorectal cancer, lung cancer, lymphoma and glioblastoma. [provided by RefSeq, Sep 2015]

Canonical amino-acid sequenceUniProt

207 residues, UniProt reviewed canonical sequence.

>P16455|MGMT
     1  MDKDCEMKRT TLDSPLGKLE LSGCEQGLHE IKLLGKGTSA ADAVEVPAPA AVLGGPEPLM
    61  QCTAWLNAYF HQPEAIEEFP VPALHHPVFQ QESFTRQVLW KLLKVVKFGE VISYQQLAAL
   121  AGNPKAARAV GGAMRGNPVP ILIPCHRVVC SSGAVGNYSG GLAVKEWLLA HEGHRLGKPG
   181  LGGSSGLAGA WLKGAGATSG SPPAGRN

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against MGMT can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.34
Highest tissue expression
126 nTPM

Expression across tissuesHPA

Tissue

  • liver: 126 nTPM
  • kidney: 37 nTPM
  • choroid plexus: 32 nTPM
  • pancreas: 30 nTPM
  • adipose tissue: 30 nTPM
  • breast: 28 nTPM

Single-cell type

  • hepatocytes: 649 nCPM
  • gastric progenitor cells: 260 nCPM
  • respiratory ciliated cells: 251 nCPM
  • late spermatids: 200 nCPM
  • fallopian tube ciliated cells: 196 nCPM
  • proximal tubule cells: 185 nCPM

Immune cell

  • T-reg: 54 nTPM
  • memory B-cell: 50 nTPM
  • NK-cell: 50 nTPM
  • naive B-cell: 48 nTPM
  • gdT-cell: 44 nTPM
  • plasmacytoid DC: 44 nTPM

Brain region

  • choroid plexus: 19 nTPM
  • medulla oblongata: 18 nTPM
  • pons: 17 nTPM
  • midbrain: 17 nTPM
  • thalamus: 16 nTPM
  • basal ganglia: 16 nTPM

ReferencesPubMed · IEDB

Publications for MGMT from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.

Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.78
gnomAD pLI
0
gnomAD missense Z
-0.62
DepMap mean gene effect
0.09
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

  • Winged helix-like DNA-binding domain superfamily
  • Methylated-DNA-[protein]-cysteine S-methyltransferase, active site
  • Methylguanine DNA methyltransferase, ribonuclease-like domain
  • Methylated-DNA-[protein]-cysteine S-methyltransferase, DNA binding
  • Methylated DNA-protein cysteine methyltransferase, DNA binding domain
  • Methylated DNA-protein cysteine methyltransferase domain superfamily
  • 6-O-methylguanine DNA methyltransferase, DNA binding domain
  • 6-O-methylguanine DNA methyltransferase, ribonuclease-like domain

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads MGMT as an antibody target. Whether an autoantibody or antibody against MGMT could matter depends on whether native MGMT is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

MGMT is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label MGMT as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/MGMT. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...